Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Induction of eosinophil apoptosis by hydrogen peroxide promotes the resolution of allergic inflammation.

Reis AC, Alessandri AL, Athayde RM, Perez DA, Vago JP, Ávila TV, Ferreira TP, de Arantes AC, Coutinho Dde S, Rachid MA, Sousa LP, Martins MA, Menezes GB, Rossi AG, Teixeira MM, Pinho V.

Cell Death Dis. 2015 Feb 12;6:e1632. doi: 10.1038/cddis.2014.580.

2.

Wogonin induces eosinophil apoptosis and attenuates allergic airway inflammation.

Lucas CD, Dorward DA, Sharma S, Rennie J, Felton JM, Alessandri AL, Duffin R, Schwarze J, Haslett C, Rossi AG.

Am J Respir Crit Care Med. 2015 Mar 15;191(6):626-36. doi: 10.1164/rccm.201408-1565OC.

3.

Assays of eosinophil apoptosis and phagocytic uptake.

Dorward DA, Sharma S, Alessandri AL, Rossi AG, Lucas CD.

Methods Mol Biol. 2014;1178:177-95. doi: 10.1007/978-1-4939-1016-8_16.

PMID:
24986617
4.

Soluble tumour necrosis factor receptor-1 (sTNFR1) levels are positively associated with exercise intensity in athletes after strenuous off-road cycling.

Pussieldi GA, Gomes EC, Veneroso CE, De Paz JA, Fonseca TR, Mendes TT, Rossi AG, Teixeira MM, Teixeira AL, Alessandri AL.

J Sports Med Phys Fitness. 2014 Apr;54(2):225-31.

PMID:
24509995
5.

Technical advance: autofluorescence-based sorting: rapid and nonperturbing isolation of ultrapure neutrophils to determine cytokine production.

Dorward DA, Lucas CD, Alessandri AL, Marwick JA, Rossi F, Dransfield I, Haslett C, Dhaliwal K, Rossi AG.

J Leukoc Biol. 2013 Jul;94(1):193-202. doi: 10.1189/jlb.0113040. Epub 2013 May 10.

6.

Resolution of inflammation: mechanisms and opportunity for drug development.

Alessandri AL, Sousa LP, Lucas CD, Rossi AG, Pinho V, Teixeira MM.

Pharmacol Ther. 2013 Aug;139(2):189-212. doi: 10.1016/j.pharmthera.2013.04.006. Epub 2013 Apr 11. Review.

PMID:
23583354
7.

Pharmacological strategies to resolve acute inflammation.

Sousa LP, Alessandri AL, Pinho V, Teixeira MM.

Curr Opin Pharmacol. 2013 Aug;13(4):625-31. doi: 10.1016/j.coph.2013.03.007. Epub 2013 Apr 8. Review.

PMID:
23578762
8.

Induction of eosinophil apoptosis by the cyclin-dependent kinase inhibitor AT7519 promotes the resolution of eosinophil-dominant allergic inflammation.

Alessandri AL, Duffin R, Leitch AE, Lucas CD, Sheldrake TA, Dorward DA, Hirani N, Pinho V, de Sousa LP, Teixeira MM, Lyons JF, Haslett C, Rossi AG.

PLoS One. 2011;6(9):e25683. doi: 10.1371/journal.pone.0025683. Epub 2011 Sep 30.

9.

Therapeutic effects of evasin-1, a chemokine binding protein, in bleomycin-induced pulmonary fibrosis.

Russo RC, Alessandri AL, Garcia CC, Cordeiro BF, Pinho V, Cassali GD, Proudfoot AE, Teixeira MM.

Am J Respir Cell Mol Biol. 2011 Jul;45(1):72-80. doi: 10.1165/rcmb.2009-0406OC. Epub 2010 Sep 10.

PMID:
20833968
10.

PDE4 inhibition drives resolution of neutrophilic inflammation by inducing apoptosis in a PKA-PI3K/Akt-dependent and NF-kappaB-independent manner.

Sousa LP, Lopes F, Silva DM, Tavares LP, Vieira AT, Rezende BM, Carmo AF, Russo RC, Garcia CC, Bonjardim CA, Alessandri AL, Rossi AG, Pinho V, Teixeira MM.

J Leukoc Biol. 2010 May;87(5):895-904. doi: 10.1189/jlb.0809540. Epub 2010 Jan 26.

PMID:
20103769
11.

The CCL3/macrophage inflammatory protein-1alpha-binding protein evasin-1 protects from graft-versus-host disease but does not modify graft-versus-leukemia in mice.

Castor MG, Rezende B, Resende CB, Alessandri AL, Fagundes CT, Sousa LP, Arantes RM, Souza DG, Silva TA, Proudfoot AE, Teixeira MM, Pinho V.

J Immunol. 2010 Mar 1;184(5):2646-54. doi: 10.4049/jimmunol.0902614. Epub 2010 Jan 25.

12.

Treatment with a novel chemokine-binding protein or eosinophil lineage-ablation protects mice from experimental colitis.

Vieira AT, Fagundes CT, Alessandri AL, Castor MG, Guabiraba R, Borges VO, Silveira KD, Vieira EL, Gonçalves JL, Silva TA, Deruaz M, Proudfoot AE, Sousa LP, Teixeira MM.

Am J Pathol. 2009 Dec;175(6):2382-91. doi: 10.2353/ajpath.2009.090093. Epub 2009 Nov 5.

13.

The CDK inhibitor, R-roscovitine, promotes eosinophil apoptosis by down-regulation of Mcl-1.

Duffin R, Leitch AE, Sheldrake TA, Hallett JM, Meyer C, Fox S, Alessandri AL, Martin MC, Brady HJ, Teixeira MM, Dransfield I, Haslett C, Rossi AG.

FEBS Lett. 2009 Aug 6;583(15):2540-6. doi: 10.1016/j.febslet.2009.07.017. Epub 2009 Jul 18.

14.

Cyclic AMP enhances resolution of allergic pleurisy by promoting inflammatory cell apoptosis via inhibition of PI3K/Akt and NF-kappaB.

Sousa LP, Carmo AF, Rezende BM, Lopes F, Silva DM, Alessandri AL, Bonjardim CA, Rossi AG, Teixeira MM, Pinho V.

Biochem Pharmacol. 2009 Aug 15;78(4):396-405. doi: 10.1016/j.bcp.2009.04.030. Epub 2009 May 5.

PMID:
19422809
15.

Ticks produce highly selective chemokine binding proteins with antiinflammatory activity.

Déruaz M, Frauenschuh A, Alessandri AL, Dias JM, Coelho FM, Russo RC, Ferreira BR, Graham GJ, Shaw JP, Wells TN, Teixeira MM, Power CA, Proudfoot AE.

J Exp Med. 2008 Sep 1;205(9):2019-31. doi: 10.1084/jem.20072689. Epub 2008 Aug 4.

16.

Concentrations of CXCL8, CXCL9 and sTNFR1 in plasma of patients with pulmonary tuberculosis undergoing treatment.

Alessandri AL, Souza AL, Oliveira SC, Macedo GC, Teixeira MM, Teixeira AL.

Inflamm Res. 2006 Dec;55(12):528-33.

PMID:
17039284
17.

Mechanisms underlying the inhibitory effects of tachykinin receptor antagonists on eosinophil recruitment in an allergic pleurisy model in mice.

Alessandri AL, Pinho V, Souza DG, Castro MS, Klein A, Teixeira MM.

Br J Pharmacol. 2003 Nov;140(5):847-54.

18.

The role of CCL22 (MDC) for the recruitment of eosinophils during allergic pleurisy in mice.

Pinho V, Oliveira SH, Souza DG, Vasconcelos D, Alessandri AL, Lukacs NW, Teixeira MM.

J Leukoc Biol. 2003 Mar;73(3):356-62.

Supplemental Content

Loading ...
Support Center